Clinical Trials Browser

Phase 3 × osimertinib × Tumor-Agnostic × Clear all

NCT05629234 2025-12-24

ROSY-T

Phase 3 Active not recruiting

Neoplasms

NCT05261399 2025-01-10

SAFFRON

Phase 3 Recruiting

Carcinoma, Neoplasm Metastasis